MEDI SEM
ActiveSummary
MEDI SEM has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €830,562 and a net result of €63,474. Equity is growing by ~8% per year across the filed fiscal years. Its solvency ranks better than 95% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability78=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €75,000 at 30 days acceptable
short-term debt: 0.1% and cash: 97.6% of total assets, and 0.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
99.9%
Return on assets
7.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-08-2026, 5 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
5 d late
2024
29 d late
2023
66 d late
2022
4 d late
2021
26 d late
2020
60 d late
2019
27 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 31 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€830,562▲ 8.3%
2024 · €767,088
Total assets
€831,371▲ 8.4%
2024 · €767,250
Net result
€63,474▲ 11.0%
2024 · €57,191
Working capital
€830,265▲ 8.3%
2024 · €766,446
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€86,968▲ 10.0%€80,247▼ 7.7%€77,070▼ 4.0%€79,863▲ 3.6%€84,212▲ 5.4%
Net result€58,360within the sector's middle half▼ 1.0%€53,789within the sector's middle half▼ 7.8%€52,487within the sector's middle half▼ 2.4%€57,191within the sector's middle half▲ 9.0%€63,474within the sector's middle half▲ 11.0%
Equity€603,620above the sector's middle half▲ 0.7%€657,409above the sector's middle half▲ 8.9%€709,896above the sector's middle half▲ 8.0%€767,088above the sector's middle half▲ 8.1%€830,562above the sector's middle half▲ 8.3%
Total assets€604,713within the sector's middle half▼ 0.6%€657,691above the sector's middle half▲ 8.8%€710,187above the sector's middle half▲ 8.0%€767,250above the sector's middle half▲ 8.0%€831,371above the sector's middle half▲ 8.4%
Debt€1,093▼ 88.1%€281▼ 74.3%€290▲ 3.1%€162▼ 44.2%€809▲ 399%
Working capital€594,597above the sector's middle half▲ 1.5%€652,632above the sector's middle half▲ 9.8%€709,715above the sector's middle half▲ 8.7%€766,446above the sector's middle half▲ 8.0%€830,265above the sector's middle half▲ 8.3%
Solvency99.8%above the sector's middle half▲ 1.3pp100.0%above the sector's middle half▲ 0.1pp100.0%above the sector's middle half=100.0%above the sector's middle half=99.9%above the sector's middle half▼ 0.1pp
Current ratio
Return on assets (ROA)9.7%within the sector's middle half=8.2%within the sector's middle half▼ 1.5pp7.4%below the sector's middle half▼ 0.8pp7.5%below the sector's middle half▲ 0.1pp7.6%below the sector's middle half▲ 0.2pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 5% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €831,371
Fixed assets
€298 ▼ 53.6%
Current assets
€831,073 ▲ 8.4%
Equity and liabilities €831,371
Equity
€830,562 ▲ 8.3%
Debt
€809 ▲ 399%
Debt's share of the balance-sheet total rises from 0.0% to 0.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€84,556▲
2024 · €80,252
Cash flow
€63,818▲
2024 · €57,581
Debt to equity
0.00▲
2024 · 0.00
ROE
7.6%▲
2024 · 7.5%
Interest coverage
89.82▼
2024 · 95.47
Debt ≤ 1 year
€809▲
2024 · €162
Income taxes
€27,698▲
2024 · €27,238
A ratio outside any meaningful range has been withheld (balance sheet total €831,371, equity €830,562).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,134 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,134 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €4,642 | €4,609 | €4,595 | €389 | €344 | ▼ 11.6% |
| Other operating charges640/8 | €398 | €474 | €434 | €437 | €450 | ▲ 2.8% |
| Non-recurring operating charges66A | - | - | €90 | - | - | - |
| Gross operating margin9900 | €92,007 | €85,330 | €82,190 | €80,690 | €85,006 | ▲ 5.3% |
| Operating profit (loss)9901 | €86,968 | €80,247 | €77,070 | €79,863 | €84,212 | ▲ 5.4% |
| Financial income75/76B | €15 | €47 | €841 | €5,407 | €7,902 | ▲ 46.2% |
| Recurring financial income75 | €15 | €47 | €841 | €5,407 | €7,902 | ▲ 46.2% |
| Financial charges65/66B | €261 | €298 | €539 | €841 | €941 | ▲ 12.0% |
| Recurring financial charges65 | €261 | €298 | €539 | €841 | €941 | ▲ 12.0% |
| Profit (loss) for the period before taxes9903 | €86,722 | €79,996 | €77,372 | €84,429 | €91,173 | ▲ 8.0% |
| Income taxes67/77 | €28,362 | €26,207 | €24,885 | €27,238 | €27,698 | ▲ 1.7% |
| Profit (loss) for the period9904 | €58,360 | €53,789 | €52,487 | €57,191 | €63,474 | ▲ 11.0% |
| Profit (loss) for the period to be appropriated9905 | €58,360 | €53,789 | €52,487 | €57,191 | €63,474 | ▲ 11.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €604,713 | €657,691 | €710,187 | €767,250 | €831,371 | ▲ 8.4% |
| Fixed assets21/28 | €9,023 | €4,777 | €182 | €642 | €298 | ▼ 53.6% |
| Tangible fixed assets22/27 | €9,023 | €4,777 | €182 | €642 | €298 | ▼ 53.6% |
| Land and buildings22 | €525 | €225 | - | - | - | - |
| Furniture and vehicles24 | €8,498 | €4,552 | €182 | €642 | €298 | ▼ 53.6% |
| Current assets29/58 | €595,690 | €652,914 | €710,005 | €766,608 | €831,073 | ▲ 8.4% |
| Amounts receivable within one year40/41 | €9,149 | €8,421 | €16,588 | €15,850 | €17,045 | ▲ 7.5% |
| Trade receivables40 | €28 | €380 | - | - | €1,248 | - |
| Other amounts receivable41 | €9,121 | €8,041 | €16,588 | €15,850 | €15,796 | ▼ 0.3% |
| Cash at bank and in hand54/58 | €585,048 | €642,865 | €691,870 | €748,232 | €811,448 | ▲ 8.4% |
| Deferred charges and accrued income490/1 | €1,493 | €1,628 | €1,547 | €2,526 | €2,580 | ▲ 2.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €604,713 | €657,691 | €710,187 | €767,250 | €831,371 | ▲ 8.4% |
| Equity10/15 | €603,620 | €657,409 | €709,896 | €767,088 | €830,562 | ▲ 8.3% |
| Contributions10/11 | €12,392 | €14,251 | €14,251 | €12,392 | €12,392 | = |
| Reserves13 | €591,228 | €643,158 | €695,645 | €754,696 | €818,170 | ▲ 8.4% |
| Non-distributable reserves130/1 | €1,859 | - | - | - | - | - |
| Reserves not available under the articles1311 | €1,859 | - | - | - | - | - |
| Distributable reserves133 | €589,369 | €643,158 | €695,645 | €754,696 | €818,170 | ▲ 8.4% |
| Amounts payable17/49 | €1,093 | €281 | €290 | €162 | €809 | ▲ 399% |
| Amounts payable within one year42/48 | €1,093 | €281 | €290 | €162 | €809 | ▲ 399% |
| Trade debts44 | €844 | €281 | €290 | €162 | €809 | ▲ 399% |
| Suppliers440/4 | €844 | €281 | €290 | €162 | €809 | ▲ 399% |
| Other amounts payable47/48 | €249 | - | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €58,360 | €53,789 | €52,487 | €57,191 | €63,474 | ▲ 11.0% |
| + Depreciation and write-downs630 | €4,642 | €4,609 | €4,595 | €389 | €344 | ▼ 11.6% |
| Operating cash flow (approximation) | €63,002 | €58,398 | €57,082 | €57,581 | €63,818 | ▲ 10.8% |
| Investment in fixed assets (approximation) | - | -€363 | €0 | -€849 | €0 | ▲ 100% |
| Change in cash | - | €57,816 | €49,005 | €56,362 | €63,217 | ▲ 12.2% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
05-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 5 days late
2025
31-12
Financial
Highest result since 2018net €63,474 ▲11%
Net result €63,474, the highest in the series.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
05-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 66 days late
2023
04-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 4 days late
2022
31-12
Financial
Liquidity quadruplescurrent ratio 2320.48
Current ratio from 545.14 to 2320.48; short-term debt falls from €1,093 to €281.
26-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 26 days late
2021
31-12
Financial
Liquidity times 8current ratio 545.14
Current ratio from 64.63 to 545.14; short-term debt falls from €9,206 to €1,093.
29-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 60 days late
2020
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 27 days late
2019
31-12
Financial
Equity above €500,000Eq €540,450 ▲11.7%
2 profitable years in a row build equity to €540,450.
22-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 22 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 58 days late
2017
28-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Florenville
Ground area
1,819 m²
Building footprint
236 m²
Volume, LiDAR
1,765 m³
Parcel 85025E0668/00G000, Wallonia · tallest building 9.6 m, ±3 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 85025E0668/00G000 | Wallonia | 1,819 m² | 1 · 236 m² | 9.6 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokters Bogaert-Baert
BE 0645.634.077
Nieuwerkerken (Limb.) · Eq €830,324
DR SOADE NOURI
BE 0898.296.709
Nieuwerkerken (Limb.) · Eq €829,988
DR. MICHEL MAHIEU
BE 0862.450.061
Oostkamp · Eq €829,764
DR. FRANS BLAUWENS
BE 0477.165.764
Bilzen-Hoeselt · Eq €829,285
Dr. L. Van Landeghem
BE 0889.036.573
Beveren-Kruibeke-Zwijndrecht · Eq €832,014
Of 9,130 companies in sector 86210 we hold annual accounts for 6,336. 4,350 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded27-12-1990
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0442879036
Registered
17-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.